Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jul 3, 2026

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

莱卡内马布 问题

Stephen E Nadeau1

  • 1From the Neurology Service and the Brain Rehabilitation Research Center, Malcom Randall VA Medical Center; Department of Neurology, University of Florida College of Medicine, Gainesville, FL.

Neurology
|March 14, 2024
PubMed
概括
此摘要是机器生成的。

莱卡尼马布适度减缓了阿尔茨海默病的进展,但也带来了挑战. 进一步考虑其临床价值,治疗负担和潜在的副作用,如大脑缩,对于患者讨论至关重要.

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Management of chronic non-cancer pain: a framework.

Pain management·2022
Same author

Emotional and Neuropsychiatric Disorders Associated with Alzheimer's Disease.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2022
Same author

Opioid trials: time for a new approach? Enriched enrollment randomized gradual withdrawal designs.

Pain management·2022
Same author

Basal Ganglia and Thalamic Contributions to Language Function: Insights from A Parallel Distributed Processing Perspective.

Neuropsychology review·2021
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
Same journal

Cerebral Artery Pulsatility, Premorbid Blood Pressure, and Small Vessel Disease on Brain Imaging: A Population-Based Study.

Neurology·2026
Same journal

Genetic Risk for Alzheimer Disease, Midlife Hypertension, and Dementia: The ARIC Neurocognitive Study.

Neurology·2026
Same journal

What is the Relevance of Neuron-Tumor Interactions in Malignant CNS Tumors?

Neurology·2026
查看所有相关文章

科学领域:

  • 神经学 神经学
  • 临床试验 临床试验
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 莱卡尼马布是一种粉样蛋白向的单克隆抗体,已在减缓早期阿尔茨海默病进展方面表现出有效性.
  • 最近的试验结果导致FDA批准和广泛采用,需要对其临床实用性的批判性评估.
  • 有关盲目的完整性,输液反应的潜在安慰剂效应以及解释粉样蛋白相关的成像异常存在担忧.

研究的目的:

  • 批判性地评估早期阿尔茨海默病时使用莱卡内马布治疗的临床意义和益处风险概况.
  • 评估lecanemab相对于临床上重要的最小差异和现有治疗方法的影响的大小.
  • 考虑治疗负担的长期影响,时间价值折扣和潜在的不良影响,如大脑缩.

主要方法:

  • 从一项为期18个月的lecanemab随机对照试验的数据分析.
  • 通过使用临床痴呆症评分尺度 (CDR-SB) 和阿尔茨海默氏病评估尺度-认知14 (ADAS-Cog14) 评估临床结果.
  • 考虑诸如盲目的成功,参与者报告的结果,治疗负担和包括脑缩在内的不良事件等因素.

主要成果:

  • 莱卡尼马布在早期阿尔茨海默病中显示出对认知和功能衰退的统计学显著减缓.
  • 在CDR-SB上观察到的益处在最小临床重要差异的18%至46%之间.

更多相关视频

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

Harvest and Primary Culture of Leptomeningeal Lymphatic Endothelial Cells
06:44

Harvest and Primary Culture of Leptomeningeal Lymphatic Endothelial Cells

Published on: September 8, 2023

相关实验视频

Last Updated: Jul 3, 2026

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

Harvest and Primary Culture of Leptomeningeal Lymphatic Endothelial Cells
06:44

Harvest and Primary Culture of Leptomeningeal Lymphatic Endothelial Cells

Published on: September 8, 2023

  • 18个月后莱卡涅马布对ADAS-Cog14的影响是6个月后多内佩西尔的一半,治疗与渐进性脑缩有关.

    • 结论:

    • 虽然lecanemab提供了适度的益处,但由于其效果的大小和高的治疗负担,其临床价值受到争论.
    • 潜在的安慰剂效应和大脑缩的风险在患者和医生的讨论中需要仔细考虑.
    • 建议对临床试验结果措施进行重新评估并将其转化为临床实践,以确保以患者为中心的决策.